Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC11H5Cl2N3OS |
InChIKeyQLWZGYISUDNRSA-UHFFFAOYSA-N |
CAS Registry478488-83-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 11 Aug 2005 |